NSE filing, NSE: AARTIDRUGS. Summary written from the filing by ALFA Finder's alert engine.
Aarti Drugs Ltd: key numbers
- Share price
- ₹449.00
- Market cap
- ₹4,098 Cr
- Revenue (annual)
- ₹2,565 Cr
- Net profit (annual)
- ₹194.9 Cr
- P/E (TTM)
- 21.4×Sector 48.7×
- Promoter holding
- 54.07%-0.36% QoQ
- FII holding
- 2.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aarti Drugs Ltd
All →Aarti Drugs Board Meeting Date
Aarti Drugs Ltd intimated BSE and NSE of a board meeting on November 3, 2026, to consider audited financial results for the quarter and half year ended September 30, 2026. Trading window remains closed until 48 hours after results declaration.
Aarti Drugs Other Announcement
The company submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI Listing Regulations.
Aarti Drugs Other Announcement
Aarti Drugs has updated its list of authorized personnel for determining materiality of events and making stock exchange disclosures, effective October 1, 2026.
Aarti Drugs Management Change
Aarti Drugs Ltd announced the retirement of Director Uday M. Patil and the appointment of new directors, including Adhish P. Patil as the Managing Director.
Aarti Drugs Investor Presentation: Key Takeaways
Aarti Drugs reports Q1 FY27 revenue of ₹704 Cr, up 19% YoY. Management focuses on scaling regulated market sales through high-margin formulations and oncology backward integration.
Aarti Drugs Annual General Meeting
Aarti Drugs Limited conducted its 41st Annual General Meeting on September 26, 2026, to consider various ordinary and special business resolutions.
Other annual general meeting announcements
All →Wealth First Portfolio Managers Annual General Meeting
EGM notice seeks approval for preferential allotment and a ₹60 Crore RPT cap with Lakshya Asset Management. Meeting scheduled for November 21, 2026 via video conference.
Thyrocare Technologies Annual General Meeting
Thyrocare Technologies reported postal ballot voting results approving the purchase of land and building from, and divestment of its entire shareholding in, Nueclear Healthcare Limited.
Uravi Defence and Technology Annual General Meeting
Uravi Defence seeks postal ballot approval for up to Rs.6 Crore unsecured loans from directors. Remote e-voting runs October 30 to November 28, 2026.
Accord Synergy Annual General Meeting
Accord Synergy's postal ballot seeks approval for Mr. Betulla Khan's ₹5 lakh monthly remuneration as Business Development Head. E-voting closes November 30, 2026.
- Execution
- 1 year, 17 September 2026 to 16 September 2027
Globe Multi Ventures Annual General Meeting
Globe Multi Ventures filed proceedings of its 41st AGM held on October 29, 2026. E-voting results will follow after the scrutinizer's report.
Amco India Annual General Meeting
Amco India Ltd filed certified minutes of its 39th AGM held 30 September 2026 via VC/OAVM. Minutes record routine ordinary business, including adoption of FY2026 financial statements and director re-appointment.